CLINICAL PREVENTIVE MEDICINE

RECRUIT STREPTOCOCCAL INFECTION PREVENTION PROGRAM

Group A streptococcal infections continue to be a significant cause of lost training days among naval recruits. Streptococcal infections have the potential to cause severe, life threatening conditions and can significantly delay recruits’ training.

Since the 1960's, a program of group A streptococcal disease surveillance and penicillin prophylaxis has contributed to the control of streptococcal infection and its sequelae among naval recruits. BUMEDINST 6220.8B provides policy and guidelines for streptococcal disease surveillance and the use of antibiotic prophylaxis to control group A streptococcal infections among naval recruits and trainees at other high density schools and training environments.

Policy and Guidance

• BUMEDINST 6220.8B: Recruit Streptococcal Infection Prevention Program

• CDC Mpox Page
• WHO Mpox Page
• IHD Mpox Vaccine Resource Center
• DHA Mpox Guidance Update_5Sept2024

Clinical guidance, including recognition, management and clinical isolation guidance are generally covered by CDC: CDC Clinical Overview

Clinical management for Fleet medical personnel can be found in the NMCFHPC Fleet Mpox Medical Guidance

Clinical guidance for MTFs can be found in the DHA Mpox Guidance Update_5Sept2024

Currently, neither mpox testing nor treatment are readily available in a forward deployed operational setting. Units should identify suspected cases, isolate them, and move them for care at an MTF when operationally feasible.